India’s mRNA vaccine candidate advances to human testing phase

India’s first mRNA vaccine candidate, developed by Pune-based Gennova in collaboration with US HDT Bio, received approval for human trials to determine if it is safe and produces a protective immune response against the coronavirus disease (Covid-19). The Indian drug regulator’s Subject Matter Expert Committee recommended that the candidate vaccine, …

Read More »